首页> 外文期刊>Perspectives in vascular surgery and endovascular therapy. >Urgent endovascular treatment of symptomatic or contained ruptured aneurysms with modified stent grafts.
【24h】

Urgent endovascular treatment of symptomatic or contained ruptured aneurysms with modified stent grafts.

机译:改良的支架移植物对症状性或内在破裂的动脉瘤进行紧急血管内治疗。

获取原文
获取原文并翻译 | 示例
       

摘要

Anatomical constraints limit the utility of endovascular therapy with infrarenal stent grafts in approximately 40% of the patients. Fenestrated and branched stent grafts that incorporate the visceral and renal arteries are currently not approved for commercial use in the United States and require at least 6 to 8 weeks for customization. These devices are not currently available as an off-the-shelf suggest that standardization will be possible in 70% to 80% of patients. Modification of aortic stent grafts with creation of reinforced fenestrations or side branches has been reported and may have a future role in the compassionate treatment of high-risk patients with complex aneurysms who otherwise would not have access to a manufactured device, or for those in need of urgent or emergent repair as in the case of a patient with an impending or contained ruptured aneurysm. This article summarizes the current principles applied for device design, procedure planning, and potential applications of modified stent grafts for urgent treatment of symptomatic or contained ruptured aortic aneurysms.
机译:解剖学限制限制了大约40%的患者使用肾下支架移植物进行血管内治疗的实用性。结合有内脏和肾动脉的有孔的和分支的支架移植物目前在美国尚未获准用于商业用途,并且需要至少6至8周的时间进行定制。这些设备目前尚不可用,因为现成的建议表明将有可能在70%至80%的患者中实现标准化。有报道称,通过开窗或侧枝增强可以对主动脉支架移植物进行改良,并且在具有同情心的复杂动脉瘤高危患者的富有同情心的治疗中具有未来的作用,这些患者否则将无法使用人造器械,或者需要治疗的患者紧急或紧急修复,如即将或即将破裂的动脉瘤患者。本文总结了当前用于器械设计,程序计划的原理,以及改良的支架移植物在有症状或封闭性主动脉瘤紧急治疗中的潜在应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号